204 related articles for article (PubMed ID: 37309005)
1. Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets.
Luo H; Chen J; Jiang Q; Yu Y; Yang M; Luo Y; Wang X
Clin Epigenetics; 2023 Jun; 15(1):100. PubMed ID: 37309005
[TBL] [Abstract][Full Text] [Related]
2. Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
Wang L; Ding Y; Zhang C; Chen R
PLoS One; 2022; 17(5):e0269249. PubMed ID: 35639708
[TBL] [Abstract][Full Text] [Related]
3. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
4. Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma.
Pazgan-Simon M; Kucharska M; Górka-Dynysiewicz J; Simon K
Pharmacol Rep; 2022 Dec; 74(6):1306-1314. PubMed ID: 36394820
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection.
Guler-Margaritis S; Mercan-Stanciu A; Toma L; Rusie D; Isac T; Dodot M; Zgura A; Bacalbasa N; Haineala B; Badiu DC; Serban D; Iliescu EL
In Vivo; 2021; 35(6):3377-3383. PubMed ID: 34697172
[TBL] [Abstract][Full Text] [Related]
6. Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
Chen S
DNA Cell Biol; 2021 Feb; 40(2):359-372. PubMed ID: 33290144
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Liao W; Liu W; Liu X; Yuan Q; Ou Y; Qi Y; Huang W; Wang Y; Huang J
Oncotarget; 2015 Sep; 6(27):24132-47. PubMed ID: 26125229
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
10. Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity
Lau MC; Yi Y; Goh D; Cheung CCL; Tan B; Lim JCT; Joseph CR; Wee F; Lee JN; Lim X; Lim CJ; Leow WQ; Lee JY; Ng CCY; Bashiri H; Cheow PC; Chan CY; Koh YX; Tan TT; Kalimuddin S; Tai WMD; Ng JL; Low JG; Lim TKH; Liu J; Yeong JPS
Front Immunol; 2022; 13():978760. PubMed ID: 36172383
[TBL] [Abstract][Full Text] [Related]
11. Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19.
Zhang Y; Duan Z; Guan Y; Xu T; Fu Y; Li G
Front Immunol; 2023; 14():1167639. PubMed ID: 37283761
[TBL] [Abstract][Full Text] [Related]
12. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
Konwar C; Asiimwe R; Inkster AM; Merrill SM; Negri GL; Aristizabal MJ; Rider CF; MacIsaac JL; Carlsten C; Kobor MS
Epigenetics Chromatin; 2021 Dec; 14(1):54. PubMed ID: 34895312
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
14. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
[TBL] [Abstract][Full Text] [Related]
15. Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19.
Huang Y; Yuan Y; Chen S; Xu D; Xiao L; Wang X; Qin W; Liu B
Front Immunol; 2022; 13():985781. PubMed ID: 36275701
[TBL] [Abstract][Full Text] [Related]
16. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach.
Lu H; Zhu Q
Cancer Biother Radiopharm; 2021 Dec; 36(10):837-849. PubMed ID: 32598174
[No Abstract] [Full Text] [Related]
17. Identification of TAF1, SAT1, and ARHGEF9 as DNA methylation biomarkers for hepatocellular carcinoma.
Cai C; Xie X; Zhou J; Fang X; Wang F; Wang M
J Cell Physiol; 2020 Jan; 235(1):611-618. PubMed ID: 31283007
[TBL] [Abstract][Full Text] [Related]
18. Potential core genes associated with COVID-19 identified via weighted gene co-expression network analysis.
Wu C; Wu Z; Chen Y; Huang X; Tian B
Swiss Med Wkly; 2022 Nov; 152():40033. PubMed ID: 36509426
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract][Full Text] [Related]
20. Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma.
Kurokawa S; Yoneda M; Ogawa Y; Honda Y; Kessoku T; Imajo K; Saito S; Nakajima A; Hotta K
BMC Gastroenterol; 2022 Jun; 22(1):278. PubMed ID: 35655171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
